Terug
Dagbereik
€ 59,97
€ 63,01
52-Weeksbereik
€ 30,82
€ 99,50
Volume
466.806
50D / 200D Gem.
€ 69,78
/
€ 69,77
Vorige Slotkoers
€ 59,61
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -11,3 | 0,2 |
| P/B | 3,2 | 3,0 |
| ROE % | -35,9 | 3,6 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 9,9 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 110,25
+76.3%
Low: € 75,00
High: € 153,00
Forward WPA
-€ 6,89
Omzet Sch.
3,16M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,47
€ 0,72 – € 3,40
|
557,37M | 4 |
| FY2029 |
-€ 2,92
-€ 6,74 – -€ 1,43
|
353,06M | 4 |
| FY2028 |
-€ 5,47
-€ 7,76 – -€ 2,57
|
136,05M | 10 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | -€ 1,71 | -€ 1,62 | +5,2% |
| 2025-11-06 | -€ 1,48 | -€ 1,77 | -19,6% |
| 2025-08-07 | -€ 1,17 | -€ 1,58 | -35,0% |
| 2025-05-07 | -€ 0,99 | -€ 1,02 | -3,0% |
| 2025-02-27 | -€ 1,06 | -€ 0,98 | +7,5% |
| 2024-11-12 | -€ 0,98 | -€ 0,89 | +9,2% |
| 2024-08-08 | -€ 1,11 | -€ 1,03 | +7,2% |
| 2024-05-09 | -€ 1,00 | -€ 1,09 | -9,0% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -181,33M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-35,86%
ROIC-23,87%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio21,94
Interest Coverage-65,43
Waardering
P/E Ratio
-11,25
Forward P/EN/A
P/B Ratio3,23
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -212,18M |
| ROE | -35,86% | ROA | -26,30% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -181,33M |
| ROIC | -23,87% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 21,94 |
| Interest Coverage | -65,43 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -11,25 | Forward P/E | N/A |
| P/B Ratio | 3,23 | P/S Ratio | N/A |
| PEG Ratio | -0,26 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 755,75 | Fwd Earnings Yield | N/A |
| FCF Yield | -7,60% | ||
| Market Cap | 2,39B | Enterprise Value | 2,30B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -212,18M | -109,36M | -76,43M | -46,83M | -35,97M |
| EPS (Diluted) | -6,01 | -3,96 | -3,42 | -45,05 | -44,88 |
| Gross Profit | -281.000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -236,02M | -129,72M | -91,13M | -47,48M | -30,93M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 806,88M | 496,77M | 368,00M | 200,21M | 92,41M |
| Total Liabilities | 67,05M | 53,19M | 22,88M | 23,61M | 156,61M |
| Shareholders' Equity | 739,83M | 443,59M | 345,12M | 176,60M | -64,20M |
| Total Debt | 1,86M | 30,00M | 2,10M | 1,33M | 7,06M |
| Cash & Equivalents | 91,15M | 192,43M | 360,38M | 194,61M | 88,04M |
| Current Assets | 803,90M | 493,62M | 365,66M | 198,49M | 90,48M |
| Current Liabilities | 36,64M | 23,32M | 21,44M | 22,58M | 13,42M |